These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 29063718)

  • 1. GLUT
    Zhao Y; Zhang L; Peng Y; Yue Q; Hai L; Guo L; Wang Q; Wu Y
    Chem Biol Drug Des; 2018 Mar; 91(3):707-716. PubMed ID: 29063718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation for docetaxel-loaded brain targeting liposome with "lock-in" function.
    Li X; Qu B; Jin X; Hai L; Wu Y
    J Drug Target; 2014 Oct; 22(3):251-261. PubMed ID: 24313929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ascorbic acid-modified brain-specific liposomes drug delivery system with "lock-in" function.
    Xiao W; Fu Q; Zhao Y; Zhang L; Yue Q; Hai L; Guo L; Wu Y
    Chem Phys Lipids; 2019 Nov; 224():104727. PubMed ID: 30660746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of brain targeting l-ascorbic acid prodrugs of ibuprofen with "lock-in" function.
    Zhao Y; Qu B; Wu X; Li X; Liu Q; Jin X; Guo L; Hai L; Wu Y
    Eur J Med Chem; 2014 Jul; 82():314-23. PubMed ID: 24927052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venlafaxine: a structurally unique and novel antidepressant.
    Morton WA; Sonne SC; Verga MA
    Ann Pharmacother; 1995 Apr; 29(4):387-95. PubMed ID: 7633018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical drug-drug interactions: focus on venlafaxine.
    Magalhães P; Alves G; LLerena A; Falcão A
    Drug Metab Pers Ther; 2015 Mar; 30(1):3-17. PubMed ID: 24964257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced anti-hepatocarcinoma efficacy by GLUT1 targeting and cellular microenvironment-responsive PAMAM-camptothecin conjugate.
    Ma P; Sun Y; Chen J; Li H; Zhu H; Gao X; Bi X; Zhang Y
    Drug Deliv; 2018 Nov; 25(1):153-165. PubMed ID: 29282992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venlafaxine. A review of its pharmacology and therapeutic potential in depression.
    Holliday SM; Benfield P
    Drugs; 1995 Feb; 49(2):280-94. PubMed ID: 7729333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients.
    Godoy AL; Rocha A; da Silva Souza C; Lanchote VL
    J Clin Pharmacol; 2016 May; 56(5):567-75. PubMed ID: 26331791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring a post-traumatic stress disorder paradigm in Flinders sensitive line rats to model treatment-resistant depression II: response to antidepressant augmentation strategies.
    Brand SJ; Harvey BH
    Acta Neuropsychiatr; 2017 Aug; 29(4):207-221. PubMed ID: 27692010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of glucose transporters in the distribution of p-aminophenyl-α-d-mannopyranoside modified liposomes within mice brain.
    Du D; Chang N; Sun S; Li M; Yu H; Liu M; Liu X; Wang G; Li H; Liu X; Geng S; Wang Q; Peng H
    J Control Release; 2014 May; 182():99-110. PubMed ID: 24631863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of serotonin 5-HT1A receptors in the antidepressant-like effect and the antinociceptive effect of venlafaxine in mice.
    Berrocoso E; Mico JA
    Int J Neuropsychopharmacol; 2009 Feb; 12(1):61-71. PubMed ID: 18405417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressant-like activity of venlafaxine and clonidine in mice exposed to single prolonged stress - A model of post-traumatic stress disorder. Pharmacodynamic and molecular docking studies.
    Malikowska N; Fijałkowski Ł; Nowaczyk A; Popik P; Sałat K
    Brain Res; 2017 Oct; 1673():1-10. PubMed ID: 28797691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic/pharmacodynamic modelling of venlafaxine: pupillary light reflex as a test system for noradrenergic effects.
    Lindauer A; Siepmann T; Oertel R; Jung A; Ziemssen T; Jaehde U; Kirch W; Siepmann M
    Clin Pharmacokinet; 2008; 47(11):721-31. PubMed ID: 18840027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of venlafaxine on glucose homeostasis and oxidative stress in diabetic mice.
    Khanam R; Najfi H; Akhtar M; Vohora D
    Hum Exp Toxicol; 2012 Dec; 31(12):1244-50. PubMed ID: 22751285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venlafaxine loaded chitosan NPs for brain targeting: pharmacokinetic and pharmacodynamic evaluation.
    Haque S; Md S; Fazil M; Kumar M; Sahni JK; Ali J; Baboota S
    Carbohydr Polym; 2012 Jun; 89(1):72-9. PubMed ID: 24750606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of Venlafaxine in Neuropathic Pain: A Narrative Review of Optimized Treatment.
    Trouvin AP; Perrot S; Lloret-Linares C
    Clin Ther; 2017 Jun; 39(6):1104-1122. PubMed ID: 28554532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antidepressant venlafaxine disrupts brain monoamine levels and neuroendocrine responses to stress in rainbow trout.
    Melnyk-Lamont N; Best C; Gesto M; Vijayan MM
    Environ Sci Technol; 2014 Nov; 48(22):13434-42. PubMed ID: 25356744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venlafaxine occupation at the noradrenaline reuptake site: in-vivo determination in healthy volunteers.
    Melichar JK; Haida A; Rhodes C; Reynolds AH; Nutt DJ; Malizia AL
    J Psychopharmacol; 2001 Mar; 15(1):9-12. PubMed ID: 11277612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of muscarinic system with serotonin-norepinephrine reuptake inhibitor antidepressant attenuates depression in mice.
    Singh P; Singh TG
    Indian J Pharmacol; 2015; 47(4):388-93. PubMed ID: 26288470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.